Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT04520607

Public ClinicalTrials.gov record NCT04520607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 12:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-Term Extension Study Evaluating the Safety and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study OA-07 was a randomized, double-blind, placebo-controlled, Phase 3, multicenter, 2-year clinical trial that enrolled subjects from the recently completed Study OA-11 (NCT03928184). The first 48 weeks of OA-07 the trial was placebo-controlled with subjects receiving the same randomized treatment received in OA-11. Investigators, research staff and subjects remained blinded to treatment allocation. At Week 48, all subjects were administered LOR in the open-label portion of the trial.

Study identification

NCT ID
NCT04520607
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Biosplice Therapeutics, Inc.
Industry
Enrollment
276 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
41 Years to 81 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 25, 2020 (Actual)
Primary completion
Jun 30, 2023 (Actual)
Completion
Jun 30, 2023 (Actual)
Last update posted
Mar 24, 2026

2020 – 2023

United States locations

U.S. sites
42
U.S. states
20
U.S. cities
42
Facility City State ZIP Site status
Research Site Tucson Arizona 85712 —
Research Site Anaheim California 92805 —
Research Site Pomona California 91767 —
Research Site San Diego California 92103 —
Research Site Thousand Oaks California 91360 —
Research Site Denver Colorado 80209 —
Research Site Hialeah Florida 33016 —
Research Site Miami Florida 33173 —
Research Site Miami Lakes Florida 33014 —
Research Site Port Orange Florida 32127 —
Research Site West Palm Beach Florida 33409 —
Research Site Winter Haven Florida 33880 —
Research Site Winter Park Florida 32789 —
Research Site Newnan Georgia 30265 —
Research Site Woodstock Georgia 30189 —
Research Site Gurnee Illinois 60031 —
Research Site Oak Brook Illinois 60523 —
Research Site Valparaiso Indiana 46383 —
Research Site New Orleans Louisiana 70124 —
Research Site Bay City Michigan 48706 —
Research Site Troy Michigan 48085 —
Research Site Hazelwood Missouri 63042 —
Research Site St Louis Missouri 63141 —
Research Site Omaha Nebraska 68114 —
Research Site Hartsdale New York 10530 —
Research Site New York New York 10016 —
Research Site Rochester New York 14609 —
Research Site Charlotte North Carolina 28209 —
Research Site Salisbury North Carolina 28144 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Cincinnati Ohio 45242 —
Research Site Columbus Ohio 43235 —
Research Site Oklahoma City Oklahoma 73103 —
Research Site Fort Mill South Carolina 29707 —
Research Site Mt. Pleasant South Carolina 29464 —
Research Site Rapid City South Dakota 57702 —
Research Site Carrollton Texas 75007 —
Research Site Plano Texas 75075 —
Research Site San Antonio Texas 78229 —
Research Site Draper Utah 84020 —
Research Site Salt Lake City Utah 84107 —
Research Site Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04520607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04520607 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →